It has been validated for detection of SMN in human peripheral blood mononuclear cells (PBMCs) and has been used to measure SMN protein in brain, spinal cord, liver heart, skin and muscle tissues in a widely used transgenic mouse model of severe SMA. Here, SMN2 is linked to proximal spinal muscular atrophy.